Chimeric Therapeutics Limited (ASX:CHM)
Australia
· Delayed Price · Currency is AUD 0.0020
0.00 (0.00%)
Mar 9, 2026, 2:52 PM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 8.84 million as of March 9, 2026. Its market cap has decreased by -6.49% in one year.
Market Cap
8.84M
Enterprise Value
6.33M
Revenue
9.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 8.84M, a decrease of -90.94%. That is a compound annual growth rate of -37.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 8.84M | 7.54% |
| Dec 31, 2025 | 8.22M | -25.46% |
| Dec 31, 2024 | 11.02M | -56.60% |
| Dec 29, 2023 | 25.40M | -27.35% |
| Dec 30, 2022 | 34.97M | -59.93% |
| Dec 31, 2021 | 87.26M | -10.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invex Therapeutics | 9.02M |
| Biotron | 8.11M |
| Immuron | 9.80M |
| Tissue Repair | 9.98M |
| Bio-Gene Technology | 10.68M |
| AdAlta | 11.47M |
| Vectus Biosystems | 6.68M |
| Zelira Therapeutics | 5.95M |